•  Venture

StartEngine Review

StartEngine is one of the largest investment crowdfunding platforms, using Reg CF and Reg A+ (as well as Reg D) for certain side-by-side offerings) to offer investments in startups to anyone, in some cases for as little as $100. The selection is broad, and spans a wide range of industries from fashion to health care to electric vehicles, but investors should know curation is very limited, so investment quality can vary widely among available offerings.

StartEngine

  • Investment Types: Venture
  • Sectors: Cleantech, Food/Beverage, Robotics, Sports, and Transportation
  • Minimum Investment: $100
  • Open to all investors
 Pros
  • One of the largest Reg CF investment platforms, with very wide selection of available investments (60+ as of this writing)
  • Low investment minimums
  • Very detailed investor presentations, with easy to find Q&A history
  • Many investments also offer perks at various investment levels
  • Services available across the entire US, catering to various property types.
 Cons
  • No curation or due diligence of offerings (beyond minimum background checks and anti-fraud checks)
  • Valuations set entirely by company raising money
  • Confusing network of related entities
  • Accepts investments via credit card, which seems irresponsible
  • Startup investments are already inherently risky and illiquid, and additional uncertainty around cannabis industry adds to that risk

Overview

This StartEngine Review will help you learn more about StartEngine's investment offerings, including how the alternative investments on StartEngine are structured, and what your potential returns might be. You can read more about the criteria we use to review investment platforms here.

StartEngine is a Title III Funding Portal (aka Reg CF) registered with the SEC and governed by FINRA, and they also operate an entity for raising money via Title IV (Reg A+). While some investment crowdfunding sites take a highly curatorial approach to selecting companies, StartEngine is among the platforms with more of an open marketplace philosophy, with offering companies subjected only to minimal due diligence to screen out “bad actors” and ensure baseline compliance with SEC rules.

Is StartEngine Legit?

Yes, StartEngine is “legit” in the sense that it is a legitimate, regulated business and is a legit investment option open to anyone over the age of 18.

StartEngine is among a growing crop of crowdfunding and online alternative investment platforms, most of which have launched in the wake of the 2012 JOBS Act.

In the second half of 2017, StartEngine began rapidly accelerating their number of new offerings, and in early 2018 overtook Wefunder for total new Reg CF offerings. The company reported generating more than $4.9 million in revenue in 2018, with more than $80 million invested on the platform from 180,000 registered users.

Types of investments StartEngine offers

StartEngine offers investments in startups and growth-stage companies. Earlier-stage startups are generally riskier, though may offer the potential for a greater return in the long run (that is, if they return anything at all). StartEngine’s investment span a wide range of industries and verticals, from apparel to mobile apps, to solar, to electric vehicles, and much more.

Recently StartEngine also began offering “Initial Coin Offerings”, known as ICOs, which leverage the emerging cryptocurrency ecosystem. Cryptocurrencies and ICOs are very new, and investors should exercise extra caution while exploring them as investments. Notably in addition to startups and ICOs, StartEngine currently offers investors the opportunity to invest in StartEngine itself using a Reg A+ offering. These ICOs come in the form of Security Token Offering (STO), or cryptocurrencies representing equity in a company. Tokens and cryptocurrencies are still very new additions to the investment landscape, and investors should exercise caution and be sure to fully understand what they’re investing in.

What do you get when investing with StartEngine?

The specific security types vary by investment, but usually investors receive common stock or a convertible note. All of the offerings on StartEngine appear to be direct investments, rather than through a special-purpose vehicle like an LLC. Investors in ICOs may receive “token” units denominated in a cryptocurrency.

How does StartEngine make money?

There are no fees to investors. StartEngine charges companies that raise money on their platform 6-8% of the amount raised. However, issuers can offset these costs by charging a processing fee of 2.5% to investors which is charged on top of the price of shares.

Potential returns and cashflow

Investments on StartEngine are high-risk investments in startups and growth companies. There are no interest or dividend payments, and except under very limited circumstances, the investment must be held for at least 12 months, with minimal expectation of any market after that period. Most startup investments lose some or all of their value.

Breadth of offerings on StartEngine

StartEngine has a wide selection of investments available (more than 60 as of mid 2019), but as covered below StartEngine does not curate their offerings at all. So while some other platforms (such as SeedInvest and Microventures) advertise that only a small percentage of companies applying ever make it in front of investors, StartEngine takes the opposite approach (similar to Wefunder). Offerings span a range of industries and types of companies, including some like sportswear, movies – and even a lice clinic – that rarely come to mind when thinking about “startups”, but may be able to rally enthusiastic customer bases to participate in their offerings.

Regulatory framework

While some other platforms emphasize their curatorial approach to reviewing companies looking to raise money (like SeedInvest, which advertises that fewer than 1% of companies that apply are approved for listing), StartEngine clearly takes a different approach, performing only the minimum due diligence required to screen out “bad actors” and ensure compliance with SEC filings.

That approach does mean there’s a lot of investment choices available on StartEngine, but it’s an important difference in approach that prospective investors should be aware of in considering investments and performing their own due diligence.

This review was first published on 25 March 2017, and last updated on 04 May 2019.


Our Rating

Excellent

More about our ratings

Share this review:

Active Offerings from StartEngine

Belle Isle offering thumbnail image}}
Belle Isle

Belle Isle is a craft spirit company in Richmond Virginia, creating premium products in the moonshine category. The company has passed the 15,000 9L case mark in 2022 and its Virginia case sales have increased by 70% since the start of Covid in 2020, putting the company firmly within the top 10% of all craft spirits brands in the US by volume. Belle Isle recently sold its 1,000,000th bottle and canned cocktail!

Read More

Lit Vodka offering thumbnail image}}
Lit Vodka

Lit Vodka is a bold new ultra-premium vodka delivering thrilling branding and affordable luxury in Tennessee and Georgia with plans of expansion to other states.

Read More

Atlas News offering thumbnail image}}
Atlas News

Atlas News, Inc. (“Atlas News” or the “Company”) is a news & media company with journalists from intelligence backgrounds using technology to create original, needle-moving content that is unbiased and unfiltered.

Read More

Robot Cache offering thumbnail image}}
Robot Cache

We’re revolutionizing online PC game sales with a groundbreaking digital storefront. We enable gamers to buy and sell their PC games worldwide, making us a unique platform in the industry with gamers in over 160 countries.

Read More

CancerVax offering thumbnail image}}
CancerVax

CancerVAX is a pre-clinical, pre-revenue biotech company developing a universal cancer vaccine that uses the body’s immune system to fight cancer.

Read More

Oncolyze offering thumbnail image}}
Oncolyze

Oncolyze is a preclinical stage biotechnology company which is developing an innovative new cancer drug that selectively attacks cancer cells by causing them to explode and die while leaving normal cells intact.

Read More

iMetabolic BioPharma offering thumbnail image}}
iMetabolic BioPharma

iMetabolic Biopharma Corporation (iMBP) is an early-stage drug discovery company innovating at the intersection of technology and biotechnology to develop new, life-saving drugs to fight against some of today’s most devastating chronic diseases affecting our loved ones. Currently, we are pre-market, advancing five different disease asset programs, and in the process of developing a proprietary technological platform for the discovery of more effective and less expensive drugs. This will allow us to continuously expand our drug pipeline while increasing company value.

Read More

  • Sponsored content
  • Other Investment Opportunities

    CEO interviews